Skip to main content
Premium Trial:

Request an Annual Quote

Helge Bastian, Fran DiNuzzo, Jose Ordovas, Dennis Grimaud

Sigma-Aldrich has hired Helge Bastian to be vice president of global marketing in the company’s Research Biotech unit. Bastian formerly was executive vice president of life sciences services at SGS, and he held various positions at Qiagen, including vice president of global strategic marketing and VP of molecular diagnostics.

Fran DiNuzzo will take on the post of executive vice president and chief commercial officer at Strategic Diagnostics. DiNuzzo formerly was an executive in the BioAnalytical business unit at Agilent Technologies, serving as vice president and general manager of Chemical Solutions, the company’s services business, and its Integrated Biology Solutions business.

Jose Ordovas
has joined Progenika’s scientific advisory board. Ordovas specializes in the genetics of cardiovascular disease, has participated in the Framingham Heart Study for over twenty years, and sits on committees at the American Heart Association and the National Institutes of Health, the company said.

Med BioGene has appointed Dennis Grimaud to its board of directors. Grimaud is CEO of Theragnostix Reference Laboratories and has 20 years of entrepreneurial and executive experience in biotechnology and molecular diagnostics, including two years as CEO of Genaco Biomedical Products.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.